Status:
COMPLETED
The Role of Blood Purification by Hemoadsorption as Adjunctive Treatment in Children With Septic Shock
Lead Sponsor:
Chulalongkorn University
Conditions:
Septic Shock
Multi Organ Failure
Eligibility:
All Genders
1-15 years
Phase:
NA
Brief Summary
Sepsis is a major healthcare problem and leading cause of death in the pediatric population. Despite advances in supportive care of critically ill patients, sepsis remains an important cause of death ...
Detailed Description
Study design This pilot study is the prospective interventional cohort study with comparison to a historical control group at a nine-bed PICU at a university referral hospital. Children with septic sh...
Eligibility Criteria
Inclusion
- Children were 30 days to 15 years of age, who required any dose of at least one vasopressor and one of following
- Pediatric Logistic Organ Dysfunction (PELOD)-2 score ≥ 10
- Pediatric Risk of Mortality (PRISM)-3 score ≥ 15
Exclusion
- Patients receiving end-of-life support
- Patients who uncontrolled bleeding
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05401695
Start Date
July 1 2021
End Date
April 30 2022
Last Update
June 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Chulalongkorn University
Bangkok, Thailand, 10330